1. Home
  2. EYPT vs MATW Comparison

EYPT vs MATW Comparison

Compare EYPT & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • MATW
  • Stock Information
  • Founded
  • EYPT 1987
  • MATW 1850
  • Country
  • EYPT United States
  • MATW United States
  • Employees
  • EYPT N/A
  • MATW 11000
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • MATW Metal Fabrications
  • Sector
  • EYPT Industrials
  • MATW Telecommunications
  • Exchange
  • EYPT Nasdaq
  • MATW Nasdaq
  • Market Cap
  • EYPT 741.0M
  • MATW 797.2M
  • IPO Year
  • EYPT 2005
  • MATW 1994
  • Fundamental
  • Price
  • EYPT $13.76
  • MATW $25.89
  • Analyst Decision
  • EYPT Strong Buy
  • MATW Strong Buy
  • Analyst Count
  • EYPT 6
  • MATW 1
  • Target Price
  • EYPT $25.83
  • MATW $40.00
  • AVG Volume (30 Days)
  • EYPT 823.7K
  • MATW 180.6K
  • Earning Date
  • EYPT 11-06-2025
  • MATW 08-05-2025
  • Dividend Yield
  • EYPT N/A
  • MATW 3.86%
  • EPS Growth
  • EYPT N/A
  • MATW N/A
  • EPS
  • EYPT N/A
  • MATW N/A
  • Revenue
  • EYPT $51,898,000.00
  • MATW $1,625,543,000.00
  • Revenue This Year
  • EYPT N/A
  • MATW N/A
  • Revenue Next Year
  • EYPT N/A
  • MATW N/A
  • P/E Ratio
  • EYPT N/A
  • MATW N/A
  • Revenue Growth
  • EYPT 2.99
  • MATW N/A
  • 52 Week Low
  • EYPT $3.91
  • MATW $18.50
  • 52 Week High
  • EYPT $14.42
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 66.97
  • MATW 59.92
  • Support Level
  • EYPT $12.88
  • MATW $24.90
  • Resistance Level
  • EYPT $14.15
  • MATW $26.15
  • Average True Range (ATR)
  • EYPT 0.76
  • MATW 0.76
  • MACD
  • EYPT 0.02
  • MATW 0.10
  • Stochastic Oscillator
  • EYPT 79.11
  • MATW 89.12

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: